Safety, Tolerability, and Efficacy Study of MB07803 Administered to Patients With Type 2 Diabetes Mellitus
Status:
Completed
Trial end date:
2008-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to collect important information regarding the safety,
tolerability, and efficacy of MB07803 when administered for 28 days in patients with type 2
diabetes mellitus